ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,300,000 | -25.3% | 2,500,000 | -28.6% | 0.01% | -33.3% |
| Q2 2023 | $1,739,150 | +23.9% | 3,500,000 | 0.0% | 0.01% | +28.6% |
| Q1 2023 | $1,403,850 | -27.1% | 3,500,000 | 0.0% | 0.01% | -50.0% |
| Q4 2022 | $1,925,000 | -2.3% | 3,500,000 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $1,971,000 | +1.7% | 3,500,000 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $1,938,000 | +7.4% | 3,500,000 | 0.0% | 0.01% | +80.0% |
| Q1 2022 | $1,805,000 | -2.2% | 3,500,000 | 0.0% | 0.01% | +66.7% |
| Q4 2021 | $1,846,000 | – | 3,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 31,354,000 | $20,870 | 6.49% |
| Affinity Asset Advisors, LLC | 6,925,000 | $3,441,033 | 1.20% |
| Context Capital Management, LLC | 21,351 | $10,609 | 0.96% |
| DCF Advisers, LLC | 3,050,000 | $1,532,625 | 0.81% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 32,000,000 | $16,080,000 | 0.71% |
| SILVERBACK ASSET MANAGEMENT LLC | 7,500,000 | $3,750,000 | 0.51% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 31,025,000 | $15,106,073 | 0.32% |
| WHITEBOX ADVISORS LLC | 17,600,000 | $8,569,440 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $10,100,000 | 0.21% |
| READYSTATE ASSET MANAGEMENT LP | 5,500,000 | $2,732,950 | 0.20% |